GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE Uses, Dosage, Side Effects and more
GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE is under investigation in clinical trial NCT03081676 (The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea).
Trade Name | GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE |
Generic | Gastric inhibitory polypeptide |
Gastric inhibitory polypeptide Other Names | GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |